Maternal thrombophilia as a predictor of the onset of obstetric complications and perinatal losses in women with loss of pregnancy, depending on body weight




phenotype, pregnancy, loss of pregnancy, obesity, thrombophilia, gestational complications, hemostasis system


The article gives a scientific and practical justification for the timely detection of maternal thrombophilia at the stage of pregnancy planning taking into account the phenotype of a woman. The aim of the study was to analyze the structure of the revealed gene polymorphisms and their effect on the course of the gestational process and the hemostasis system in pregnant women, depending on the phenotype.

Clinical groups were 175 pregnant women with different body weight (120 women with overweight and obesity and 55 pregnant women with normal body weight). The average age of pregnant women in Group I was 30.9 ± 0.4 years, in Group II – 30.3 ± 0.6 years, the average gestational age at the time of registration was 9.39 ± 0.59 and 8.42 ± 0.69 weeks respectively.

The influence of intergenic interactions of genes-candidates of thrombophilia and the disturbance of folate metabolism on the occurrence of obstetric complications and perinatal losses in these women was assessed. The mechanisms of development of obstetric complications are clarified depending on the body weight taking into account their genetic determinancy. In particular, carriers of thrombophilia genes in women with miscarriage in 100% of cases, regardless of body weight, have been identified.

As the author of the article points out, obesity during pregnancy can cause serious complications for the mother and fetus. Therefore, studies on maternal thrombophilia should be conducted at the pregravidel stage in order to conduct timely pathogenetically based treatment with emphasis on therapy in the fertile cycle, which will improve perinatal outcomes in such women.

Author Biography

Ю. М. Дука, Dnipro Medical Academy of the MOH of Ukraine

MD, associate professor at the Department of Obstetrics, Gynecology and Perinatology, Faculty of Postgraduate Education


  1. Ailamazyan, E.K., Zainulina, M.S. “Hereditary thrombophilia: a differential approach to assessing the risk of obstetric complications.” Оbstetrics and gynecology 3 (2010): 3–9.
  2. Kiryushchenkov, P.A., Shmakov, R.G., Andamova, E.V., et al. “Algorithm of clinical-gemostaziologic examination in obstetric-gynecological practice.” Оbstetrics and gynecology 1 (2013): 101–6.
  3. Bitsadze, V.O. “Pathogenesis, the principles of diagnosis and prevention of complications of pregnancy, caused by thrombophilia.” Thesis abstract for MD degree, specialty 14.01.01 «Obstetrics and gynecology». Moscow (2004): 41 p.
  4. Bondar, T.P., Muratova, A.Y. “Genetic factors of development of thrombophilia in pregnant women.” Bulletin of the Peoples’ Friendship University of Russia. Series “Medicine” 1.1 (2012): 119–20.
  5. Gazieva, I.А., Chistyakova, G.N., Kovalev, V.V. “Polymorphisms of folate metabolism genes and endothelial function indexes in early pregnancy: risk factors for gestational complications development.” Obstetrics and Gynecology 1 (2013): 57–62.
  6. Alegina, E.V., Tetruashvili, N.K., Agadzhanov, A.A., et al. “Gene polymorphism as a factor predisposing to the usual loss of pregnancy.” Obstetrics and gynecology 4 (2014): 25–31.
  7. Makatsariya, A.D., Beloborodova, E.V., Bitsadze, V.O., Baymuradova, S.M. Hyperhomocysteinemia and pregnancy complications. Moscow. Triada-X (2005): 216 p.
  8. Trifonova, E.A., Gabidulina, Т.V., Agarkova, Т.А., et al. “Homocysteine, polymorphism of the MTHFR gene and complications of pregnancy.” Obstetrics and gynecology 2 (2011): 8–15.
  9. Dedov, I.I. Morbid obesity. Moscow. LLS «MIA» (2014): 608 p.
  10. Dolgushina, V.F., Vereina, N.K. “Genetic and acquired factors of thrombosis in women in obstetric pathology in the anamnesis.” Obstetrics and Gynecology 3 (2011): 27–31.
  11. Pshenichnikova, T.B., Perederyayeva, E.B., Donina, E.V., et al. “Place of thrombophilia in the structure of fetal loss syndrome in women with metabolic syndrome.” Obstetrics, gynecology and reproductology 7.4 (2013): 35–43.
  12. Makatsariya, A.D., Pshenichnikova, E.B., Pshenichnikova, Т.B., Bitsadze, V.O. Metabolic syndrome and thrombophilia in obstetrics and gynecology. Moscow. LLS «MIA» (2006): 480 p.
  13. Momot, A.P. Modern methods of recognition of thrombophilic readiness status. Barnaul. Publishing house of Altaisk State University (2011): 138 p.
  14. Momot, A.P., Taranenko, I.A., Tsyvkina, L.P. “Evolution of ideas about thrombophilia and its role in the problems of human reproduction.” Obstetrics and Gynecology 2 (2013): 4–9.
  15. Ozolinya, L.A. “The importance of hyperhomocysteinemia and the possibility of its correction in obstetrical practice.” Health of Ukraine 10 (2008): 63–6.
  16. Fetisova, I.N., Dobrolyubov, A.S., Lipin, M.A., et al. “Polymorphism of folate metabolism genes and human diseases.” Bulletin of new medical technologies 10.1 (2007): 23–8.
  17. Pshenichnikova, E.B., Pshenichnikova, Т.B., Makatsariya, A.D. “The role of thrombophilia in the development of obstetric pathology in women with metabolic syndrome.” Obstetrics and Gynecology 4 (2006): 15–9.
  18. Rebrova, O.Y. Statistical analysis of medical data. Application of STATISTICA package. Moscow. Media Sfera (2002): 312 p.



How to Cite

Дука, Ю. М. (2018). Maternal thrombophilia as a predictor of the onset of obstetric complications and perinatal losses in women with loss of pregnancy, depending on body weight. REPRODUCTIVE ENDOCRINOLOGY, (42), 68–74.



Pregnancy and childbirth